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A number of events preceding the interaction of a drug with the biological target
and/or pharmacological effect have to be considered, and these involve absorption, dis-
tribution, metabolism and elimination. In order to assess the importance of each of these
factors on drug action, both structural and physico-chemical properties of the drug should
be taken into account (1). In biological systems, properties such as electrostatic bonds,
hydrogen bonds, van der Waals bonds, as well as effects related to electron-transfer and
the hydrophobic effects are of major importance. Although the hydrogen bond is fairly
weak compared to other interactions, it is of paramount importance in biological sys-
tems. Investigations of drug metabolism, its biotransformation pathways and structure
of formed metabolites are of toxicological, pharmacological and biomedical interest (2).
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Gentisamide (GAM, 2,5-dihydroxybenzamide), a minor
first-pass metabolite of salicylamide (SAM, 2-hydroxy-
benzamide), was studied using FT-IR, 1D and 2D homo-
and heteronuclear 1H and 13C NMR spectroscopy.
GAM was isolated from human urine eight hours after
oral administration of SAM. FT-IR, 1H and 13C NMR spec-
tra unequivocally confirmed the chemical structure of
GAM through chemical and substituent shifts, coupling
constants and connectivities in COSY, NOESY, HETCOR
and HBMC spectra.
From NOESY spectra of GAM in DMSO-d6, it was con-
cluded that the amide protons are oriented toward the or-
tho-proton at C-6. Obtained results indicate that the pres-
ence of the additional phenol group at C-5 in GAM fa-
vours the formation of intramolecular hydrogen bonding
of the O…HO type between C2-OH proton and oxygen
atom of the amide group.
Keywords: gentisamide, NSAID, salicylamide, biotransfor-
mation, FT-IR, 1D and 2D homo- and heteronuclear 1H
and 13C NMR
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However, differentiation of structurally related metabolites in biological material could
sometimes be very complex (3).
On the other hand, the separation, identification and quantitative analysis of aro-
matic carboxylic acids and their derivatives are necessary because of their importance as
nonsteroidal antiinflamatory drugs (NSAID), semi-products of biosynthesis of aromatic
amino acids in plants (phenolic acids), metabolites of numerous toxic substances, in-
cluding metabolites of drugs, as well as endogenous catecholamines (adrenaline, nor-
adrenaline and dopamine) (4).
164
M. Jadrijevi}-Mladar Taka~ et al.: FT-IR and NMR spectroscopic studies of salicylic acid derivatives. I. Gentisamide – a metabolite of









































































Scheme 1. Biotransformation of salicylamide (SAM) and gentisamide (GAM) (8).
The NSAID salicylamide (SAM) is an effective analgesic for relieving minor muscle
aches, headaches, pain associated with sinus congestion as well as for reducing fever (5).
Although SAM is not as effective as acetylsalicylic acid (ASA) or paracetamol, it is still
used in combined medicinal products for symptoms associated with cold and influenza.
The mechanism of its action is based on inhibition of arachidonic acid cyclooxygenase
(COX) and the metabolic pathway of SAM is well known (6–11). After oral administra-
tion, it is rapidly metabolized to its first-pass metabolites, SAM-glucuronide, SAM-sul-
fate and gentisamide (GAM) as a minor metabolite (Scheme 1) (8). The sulfation of SAM
is the main pathway of biotransformation while glucuronidation and hydroxylation are
of lesser importance. GAM, the 5-hydroxylated metabolite of SAM, formed in the body
by catalytic action of cytochrome P450 (CYP) enzymes, undergoes further biotransfor-
mation to its monoconjugated metabolites GAM-sulfate and GAM-glucuronide, thus
providing secondary metabolites of SAM (7, 10).
Numerous chromatographic and spectroscopic methods were used in monitoring
and detection of SAM and its metabolites (12–20). Although nuclear magnetic resonance
is now a unique and powerful method in detection and quantitative determination of
drugs and their metabolites, as well as toxic substances in the urine and other body flu-
ids (3, 21–24), data about the use of NMR in the structural analysis of SAM metabolites
are scarce (25, 26).
The GAM isolated from biological material was studied using FTIR, 1D and 2D homo-
and heteronuclear 1H and 13C NMR spectroscopies (27, 28), and its chemical structure
was unequivocally determined by using chemical and substituent shifts, coupling con-
stants and connectivities in COSY, NOESY, HETCOR and HBMC spectra.
EXPERIMENTAL
All chemicals used were of analytical grade. Melting point was determined on the
Boëtius Microheating Stage (Franz Küstner Nachf. KG, Germany) and remained uncor-
rected.
Spectral analyses
The IR spectra (KBr pellets) were recorded on a FT-IR Perkin Elmer Paragon 500
spectrophotometer (Perkin Elmer, UK).
The 1H and 13C one- and two-dimensional NMR spectra were recorded with a Vari-
an Gemini 300 spectrometer (Varian, USA) operating at 300 MHz and 75.5 MHz for the
1H and 13C nucleus, respectively, and a Bruker Avance DRX500 spectrometer (Bruker,
Germany), operating at 500 MHz and 125 MHz. All experiments were performed in
DMSO-d6 at 20 °C in 5-mm NMR tubes. Chemical shifts  in ppm are referred to TMS as
the internal standard.
The following spectra were recorded on a Gemini 300 spectrometer: broadband proton
decoupling, gated proton decoupling, APT, COSY-45, long-range COSY-45, NOESY, and
HETCOR. Digital resolution in one-dimensional 1H NMR spectra was: 0.20 Hz and in 13C
NMR spectra 0.60 Hz per point. In all experiments, proton decoupling was performed by
165
M. Jadrijevi}-Mladar Taka~ et al.: FT-IR and NMR spectroscopic studies of salicylic acid derivatives. I. Gentisamide – a metabolite of
salicylamide, Acta Pharm. 54 (2004) 163–176.
Waltz-16 modulation. Standard pulse sequences were used in two-dimensional experi-
ments. The COSY-45 and delayed COSY-45 spectra were measured in the magnitude mode,
while NOESY spectra in the phase-sensitive mode. In COSY-45, delayed COSY-45 and
NOESY spectra, 1024 points in F2 dimension and 256 increments in F1 dimension, subse-
quently zero-filled to 1024 points, were used. Each increment was obtained with 16 scans,
3000 Hz spectral width and a relaxation delay of 1 s. Thus, the digital resolution was 5.9 Hz
per point and 11.7 Hz per point in F2 and F1 dimensions, respectively. The delayed
COSY-45 spectra were measured with delay time, D3 of 0.25 s. The NOESY spectra were
measured with several mixing times (0.45–1.2 s). The HETCOR spectra were recorded with
2048 points in F2 dimension and 256 increments in F1 dimension, zero-filled to 512 points.
Increments were recorded with 180 scans, relaxation delay of 1 s and spectral width of
20000 Hz in F2 and 4500 Hz in F1 dimensions. The corresponding digital resolution was
19.53 and 17.6 Hz per point in F2 and F1 dimensions, respectively.
The HMBC pulsed field gradient spectra were recorded with a Bruker Avance DRX500
spectrometer. Absolute value HMBC spectra were recorded with a relaxation delay of 1.5 s
and 8–16 scans per increment. The spectral width was 6600 Hz in the acquisition domain F2
and 31000 Hz in time domain F1. Data were collected into the 2048  256 acquisition matrix
and processed using a 2K  1K transformed matrix with zero filling in the F1 domain. In
HMBC spectra, the delay for the long-range couplings was set at 60 ms.
GAM isolation
GAM was isolated from urine samples of ten healthy volunteers following overnight
fasting, namely eight hours after oral self-administration of tablets containing 1000 mg
of salicylamide. The official form and written consent were obtained from the subjects
prior to the experiment. Voluntary subjects were not under any other drug therapy.
Collected urine samples (2500 mL) were divided into five portions and each 500 mL
of urine was refluxed for 5 hours following addition of 250 mL of sulfuric acid (c = 3 mol
L–1). The metabolites freed from their conjugated forms were extracted by ether up to al-
most complete depletion of the acidic urine layer. Ether extracts were collected, dried by
addition of anhydrous sodium sulfate, filtered off and evaporated. Salicylamide, salicy-
lic acid, gentisamide and gentisic acid were separated by column chromatography and
identified in the crude oily residue (silica gel 70–230 mesh ASTM, 0.063–0.200 mm, Ke-
mika, Croatia, using chloroform/methanol 19:1). Separated components were addition-
ally purified by column chromatography using acetone/ethyl acetate (17:3) as solvent
mixture. For the qualitative analysis, thin-layer chromatography was performed (2-mm
thick silica gel sheets Kieselgel 60 F254, Merck, Germany) using the following solvent
mixtures: benzene/ether/acetic acid/methanol (60:30:9:1), chloroform/methanol (19:1)
and ethyl acetate/acetone (7:3). Spots were detected under UV light (254 nm) using
iron(III)-chloride as a reagent: salicylamide and salicylic acid gave violet while gentisa-
mide and gentisic acid gave blue spots. GAM (m.p. 217–218 °C, 215–216 °C in ref. 9) was
isolated in an amount corresponding to about 5% of administered salicylamide. This is in
agreement with the literature values of 3–15% (9).
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RESULTS AND DISCUSSION
The first-pass minor 5-hydroxy metabolite of salicylamide, the gentisamide, was
isolated from urine after hydrolysis in a small quantity, amounting to 5% of the adminis-
tered dose of SAM. Salicylic acid (SA), gentisic acid (GA) and SAM were extracted to-
gether with GAM in significant quantities, yielding almost 75% of the total extracted mass.
The losses can be attributed to early urine collection and incomplete extraction, as well
as to the presence of other components, detectable only by thin-layer chromatography.
In this work, we have studied the structural features of GAM, influence of 5-OH
group on the FT-IR and NMR spectroscopic characteristics of the GAM molecule, which
also contributed to other physico-chemical properties of GAM and can be of importance
for its biological behaviour. The study of biotransformation of GAM alone in liver per-
fusate of rats (7) revealed that GAM-5-glucuronide was the major metabolite of GAM
while GAM-2-sulfate was a minor metabolite. This should not be understood only as a
consequence of the physico-chemical properties and reactivity of 5-OH group compared
to C2-OH but the steric hindrance should be also taken into account.
FT-IR spectrum of GAM (Fig. 1, Table I) revealed several absorption bands in the re-
gion of stretching vibrations of O-H and N-H bonds. Thus, the absorption bands at 
3393 and 3350 cm–1 were assigned to NH2 group, while the absorption band at  3446
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Fig. 1. FT-IR spectrum (KBr) of gen-
tisamide.
cm–1 was assigned to O-H bond at C-5. The absorption band of the other hydroxyl group
at C2-OH is most probably overlapped with the broadened band spreading from 3400 to
2700 cm–1. These findings indicate the possible association through H-bonding in the
structure of GAM. In the FT-IR spectrum of SAM (Fig. 2, Table I), the stretching absorp-
tion bands observed at  3398 and 3190 cm–1 were assigned to O-H and N-H bonds. The
absorption bands at higher wavenumbers were attributed to O-H stretching, and those
at lesser wavenumbers to N-H stretching. Although primary amides generally show two
moderate absorption bands for NH2 in this region (one for asymmetric and the other for
symmetric vibrations), this probability was rejected here because of a significant dis-
tance between these two absorption bands ( = 3398 – 3190 = 208 cm–1) and their ab-
sorption intensities (T3398 = 24.6% and T3190 = 22.6%). The broad absorption band in the
FT-IR spectrum of SAM from 3500 to 2500 cm–1 also points to the presence of H-bonding.
In the region of stretching absorption of C=O group in primary amides, two charac-
teristic bands were observed at 1674 and 1589 cm–1 for SAM and at 1665 and 1577 cm–1
for GAM. The absorption bands at higher wavenumbers were assigned to the amide I
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Fig. 2. FT-IR spectrum (KBr) of sali-
cylamide.
band and the bands at lower wavenumbers to the amide II band, which is typical of pri-
mary amides. FT-IR spectra of GAM and SAM are displayed in Figs. 3a and b.
NMR investigations of SAM and its derivatives involved so far the acidic-base pro-
ton exchange and showed that N-methyl-SAM undergoes exceptionally rapid base-cata-
lyzed proton exchange and specific base-intermolecular general acid catalysis (25). It
was also concluded from the same study that o-hydroxyl group in SAM acts as an intra-
molecular catalyst in acidifying the NH proton of amide. Additionally, Brown et al. (26)
concluded from deuterium nuclear quadrupole resonance spectra that the intramolecu-
lar H-bond in SAM at 77 K is non-linear and that the angle of the O-H…O is smaller
than 150°. On the basis of electron-absorption spectra and quantum chemical calcula-
tions, El Shahawy (13) also found that the CONH2 group is oriented toward OH group
and that the proton of ortho-hydroxyl group is bound to N-atom of CONH2 group by
H-bond. These findings were confirmed by the crystal structure and solid-state infrared
169
M. Jadrijevi}-Mladar Taka~ et al.: FT-IR and NMR spectroscopic studies of salicylic acid derivatives. I. Gentisamide – a metabolite of
salicylamide, Acta Pharm. 54 (2004) 163–176.

















Fig. 3. FT-IR spectra (KBr) of salicyl-
amide (____) and gentisamide (……) in
the region of: a) 4500 to 500 cm–1
(asorption bands at 2360 and 2341
cm–1 in both spectra belong to stret-
ching asymmetric and symmetric vi-
brations of CO2), and b) 1800–1000
cm–1.

















patterns of SAM derivatives, i.e., intramolecular hydrogen bonding between the amide
proton and phenol oxygen, and intermolecular hydrogen bonds between the amide car-
bonyl oxygen and the phenol proton were found (14).
In this work, on the basis of the NMR study of GAM in DMSO-d6, the orientation of
the amide protons toward H-6 in GAM was found, while orientation of SAM amide pro-
tons was in agreement with the theoretical and experimental results of other authors.
Thus, 1H NMR spectra of GAM and SAM in DMSO-d6 revealed two signals for amide
protons (CONH2) at  8.24 and 7.74 ppm in the 1H NMR spectrum of GAM and at  8.43
and 7.92 ppm in the 1H NMR spectrum of SAM (Table II, Figs. 4a and b). The observa-
tion of two distinct signals for amide protons was explained by hindered rotation of the
C-N bond in the amide moiety, which is typical of amides. Additionally, the signal of the
ortho-hydroxyl proton (C2-OH) was observed at 13.07 ppm in the proton spectrum of
SAM, while in the 1H NMR spectrum of GAM two signals at 12.13 and at 8.98 ppm were
assigned to C2-OH and C5-OH, respectively. In each 13C NMR spectrum of SAM and
GAM, seven signals for seven chemically and magnetically non-equivalent carbon at-
oms were observed (Table II).
The results obtained from HETCOR (Fig. 5) and HMBC spectra (Fig. 6) enabled reli-
able assignment of carbon and proton signals in GAM. From the HETCOR spectrum, the
correlations between each carbon atom and its attached proton were observed and these
correlations were helpful and important in distinguishing between substituted aromatic
C atoms and those which are not substituted. Additionally, the correlations in HMBC
spectrum allow observation of couplings between C and H atoms through more than
one bond and enable unambiguous distinguishing of protons in hydroxyl groups at C-2
and C-5. These characteristic findings from the HMBC spectrum of GAM were as fol-
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Fig. 4. Part of 1H NMR spectrum of: a) gentisamide displaying amide and aromatic protons as
well as the proton in C5-OH, b) salicylamide displaying amide and aromatic protons.
lows: C2-OH proton (12.13 ppm) is in correlation with C-1 (114.96 ppm) and C-3 (117.92
ppm) through three bonds, with C-2 (153.64 ppm) through two bonds and with carbon
atom in the C=O group (171.79 ppm) through four bonds, while the proton in C5-OH
(8.98 ppm) is in correlation with C-6 (113.83 ppm) and C-4 (121.98 ppm) through three
bonds, and with C-5 (149.15 ppm) through two bonds (Fig. 6).
It was concluded on the basis of the NOESY spectrum of GAM (Fig. 7a) that the am-
ide protons are oriented toward the ortho-proton at C-6. In turn, the hydroxyl group at
the C-2 is H-bonded to the oxygen atom in the carbonyl group of the amide moiety. Con-
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Table II. 1H and 13C NMR spectral data, chemical shifts and
coupling constants for salicylamide and gentisamide
Atom Salicylamide Gentisamide
1H-NMR  ppm (DMSO-d6)
C2-OH 13.07 12.13, s






3J = 7.9 Hz
6.86, dd
3J = 8.6 Hz, 4J = 2.0 Hz
H4 7.38, t
3J = 7.3 Hz
6.69, d
3J = 8.6 Hz, 4J = 2.0 Hz
H-5 6.85, t
3J = 7.6 Hz
–
H-6 6.89, d
3J = 7.9 Hz
7.20, d
4J = 2.0 Hz








bs – broadened singlet, s – singlet, d – doublet, t – triplet,
dd – doublet of doublets
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Fig. 5. A part of the HETCOR spectrum of gentisamide.
Fig. 6. The HMBC spectrum of gentisamide.
trary to that, theoretical and gas phase data for SAM suggested amino group orientation
toward the ortho-hydroxyl group at C-2, due to strong intramolecular hydrogen bonding
of the N...HO type (11, 12). Here, we have revealed the same situation for SAM in DMSO-d6
by NMR spectroscopy (Fig. 7b).
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Fig. 7. The NOESY spec-
trum of: a) gentisamide,
b) salicylamide.
It could be concluded from these findings that the presence of an additional phenol
group at C-5 in GAM favours the formation of the intramolecular hydrogen bonding of
the O…HO type as shown below. This was confirmed by high-temperature (100 °C) NMR
measurements.
CONCLUSIONS
The structure of gentisamide isolated from human urine C was determined by
means of FT-IR, one- and twodimensional homo- and heteronuclear 1H and 13C NMR
spectroscopy. The H-bonding was observed by FT-IR spectra. On the basis of NMR spec-
tra it was concluded that the NH2 group is oriented toward H-6. It means that intra-
molecular H-bonding of O…HO type exists between C2-OH and C=O groups of GAM,
which is contrary to the findings for SAM, where H-bonding of N…OH type exists be-
tween the C2-OH proton and the amide nitrogen atom.
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S A @ E T A K
FT-IR i NMR spektroskopska istra`ivanja derivata salicilne kiseline.
I. Gentizinamid – metabolit salicilamida
MILENA JADRIJEVI]-MLADAR TAKA^, DRA@EN VIKI]-TOPI] i TIHANA GOVOR^INOVI]
Gentizinamid (GAM), metabolit prvog prolaska salicilamida (SAM), analiziran je
uporabom FT-IR, te jednodimenzijskom i dvodimenzijskom homo- i heteronuklearnom
1H i 13C NMR spektroskopijom.
GAM je izoliran iz ljudskog urina osam sati nakon oralne primjene SAM-a, a
strukturna analiza provedena je pomo}u FT-IR, 1H i 13C NMR uporabom kemijskih i
supstituentnih pomaka, konstanti spin-spin sprege, te povezanosti u COSY, NOESY,
HETCOR i HBMC spektrima.
Iz NOESY spektara u DMSO-d
6
zaklju~eno je da su protoni amidne skupine genti-
zinamida usmjereni prema orto-protonu na C-6 polo`aju. Rezultati ukazuju na to da pri-
sustvo dodatne fenolne skupine C5-OH u GAM favorizira stvaranje intramolekulske vo-
dikove veze O...HO tipa izme|u C2-OH protona i kisika amidne skupine.
Klju~ne rije~i: gentizinamid, salicilamid, NSAID, biotransformacija, FT-IR, 1D i 2D homo- i hetero-
nuklearna 1H i 13C NMR
Farmaceutsko-biokemijski fakultet Sveu~ili{ta u Zagrebu, Zagreb
Institut Ru|er Bo{kovi}, Zagreb
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